In Vitro Activity of Tea Tree Oil Vaginal Suppositories against Candida spp. and Probiotic Vaginal Microbiota

Phytotherapy Research

Volumn 29, Issue 10, 2015, Pages 1628-1633

  Di Vito, Maura ^a,b   Mattarelli, Paola ^c   Modesto, Monica ^c   Girolamo, Antonietta ^b   Ballardini, Milva ^a   Tamburro, Annunziata ^a   Meledandri, Marcello ^a   Mondello, Francesca ^b  

^a SAN FILIPPO NERI HOSPITAL   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

amphotericin B; Bifidobacterium animalis; Candida albicans; Lactobacillus spp.; microbiota; tea tree oil

Indexed keywords

AMPHOTERICIN B; PROBIOTIC AGENT; TEA TREE OIL; ANTIFUNGAL AGENT; SUPPOSITORY;

ARTICLE; BACTERIAL STRAIN; BIFIDOBACTERIUM ANIMALIS; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG DETERMINATION; DRUG EFFICACY; FEMALE; FUNGICIDAL ACTIVITY; IN VITRO STUDY; IN VIVO STUDY; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; NONHUMAN; RECURRENT DISEASE; VAGINA CANDIDIASIS; VAGINA FLORA; CANDIDA; DRUG EFFECTS; HUMAN; LACTOBACILLUS; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; SUPPOSITORY; VAGINA;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDA ALBICANS; FEMALE; HUMANS; LACTOBACILLUS; MICROBIOTA; MIDDLE AGED; PROBIOTICS; SUPPOSITORIES; TEA TREE OIL; VAGINA;

EID: 84943450017     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5422     Document Type: Article

References (30)

1. Amund OD, Ouoba LI, Sutherland JP, Ghoddusi HB,. 2014. Assessing the effects of exposure to environmental stress on some functional properties of Bifidobacterium animalis ssp. lactis. Benef Microbes 5: 461-469.
2. Asticcioli S, Sacco L, Daturi R, et al., 2009. Trends in frequency and in vitro antifungal susceptibility patterns of Candida isolates from women attending the STD outpatients clinic of a tertiary care hospital in Northern Italy during the years 2002-2007. New Microbiol 32: 199-204.
3. Belaiche P,. 1985. Treatment of vaginal infections of Candida albicans with the essential oil of Melaleuca alternifolia. Phytotherapie 15: 13-15.
4. Biavati B, Mattarelli P,. 2012. Genus Bifidobacterium. In: Bergey's Manual of Systematic Bacteriology 2nd Edition. The Actinobacteria. vol. 5. (Eds.), Goodfellow M, Kampfer P, Busse H-J, Suzuki K-I, Ludwig W, &, Whitman WB, Springer, New York. pp. 171-206.
5. Carson CF, Hammer KA, Riley TV,. 2006. Melaleuca alternifolia (Tea Tree) oil: a review of antimicrobial and other medicinal properties. Clin Microbiol Rev 19: 50-62.
6. Cassone A,. 2015. Vulvovaginal Candida albicans infections: pathogenesis, immunity and vaccine prospects. BJOG 122 (6): 785-94.
7. CLSI. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved Standard-Seventh Edition M7-A7.
8. D'Aimmo MR, Modesto M, Biavati B,. 2007. Antibiotic resistance of lactic acid bacteria and Bifidobacterium spp. isolated from dairy and pharmaceutical products. Int J Food Microbiol 115: 35-42.
9. Danby CS, Boikov D, Rautemaa-Richardson R, Sobel JD,. 2012. Effect of pH on in vitro susceptibility of Candida glabrata and Candida albicans to 11 antifungal agents and implications for clinical use. Antimicrob Agents Chemother 56: 1403-1406.
10. EMA. Committee on Herbal Medicinal Products. 2013. Community herbal monograph on Melaleuca alternifolia (Maiden and Betch) Cheel, M. linariifolia Smith, M. dissitiflora F. Mueller and/or other species of Melaleuca, aetheroleum.
11. European Committee for Antimicrobial Susceptibility Testing (EUCAST). 2000. Definitive document. E. Def. 1.2. CMI 6: 503-508.
12. Forrer M, Kulik EM, Filippi A, Waltimo T,. 2013. The antimicrobial activity of alpha-bisabolol and tea tree oil against Solobacterium moorei, a Gram-positive bacterium associated with halitosis. Arch Oral Biol 58: 10-6.
13. Foxman B, Muraglia R, Dietz JP, Sobel JD, Wagner J,. 2013. Prevalence of recurrent vulvovaginal candidiasis in 5 European countries and the United States: results from an internet panel survey. J Low Genit Tract Dis 17: 340-345.
14. Hammer KA, Carson CF, Riley TV,. 1999. In vitro susceptibilities of lactobacilli and organisms associated with bacterial vaginosis to Melaleuca alternifolia (Tea Tree) oil. Antimicrob Agents Chemother 43 (1): 196.
15. Hammer KA, Carson CF, Riley TV, Nielsen JB,. 2006. A review of the toxicity of Melaleuca alternifolia (tea tree) oil. Food Chem Toxicol 44 (5): 616-25.
16. ISO 4730: 2004. International Organisation for Standardisation. Essential oils: Oil of Melaleuca, terpinen-4-ol type (tea tree oil). Geneva: International Organisation for Standardisation.
17. Lis-Balchin M, Hart SL, Deans SG,. 2000. Pharmacological and antimicrobial studies on different tea-tree oils (Melaleuca alternifolia, Leptospermum scoparium or Manuka and Kunzea ericoides or Kanuka), originating in Australia and New Zealand. Phytother Res 14: 623-629.
18. Low WL, Martin C, Hill DJ, Kenward MA,. 2011. Antimicrobial efficacy of silver ions in combination with tea tree oil against Pseudomonas aeruginosa, Staphylococcus aureus and Candida albicans. Int J Antimicrob Agents 37: 162-5.
19. Mertas A, Garbusińska A, Szliszka E, Jureczko A, Kowalska M, Krõl W,. 2015. The influence of tea tree oil (Melaleuca alternifolia) on fluconazole activity against fluconazole-resistant Candida albicans strains. Biomed Res Int 2015: 590470.
20. Mondello F, De Bernardis F, Girolamo A, Salvatore G, Cassone A,. 2003. In vitro and in vivo activity of tea tree oil against azole-susceptible and resistant human pathogenic yeasts. J Antimicrob Chemother 51: 1223-1229.
21. Mondello F, De Bernardis F, Girolamo A, Cassone A, Salvatore G,. 2006. In vivo activity of terpinen-4-ol, the main bioactive component of Melaleuca alternifolia Cheel (tea tree) oil against azole-susceptible and -resistant human pathogenic Candida species. BMC Infect Dis 6: 158.
22. Odds FC,. 2003. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 52 (1): 1.
23. Rosato A, Vitali C, Gallo D, Balenzano L, Mallamaci R,. 2008. The inhibition of Candida species by selected essential oils and their synergism with amphotericin B. Phytomedicine 15: 635-8.
24. Saller R, Berger T, Reichling J, and, Harkenthaf M,. 1998. Pharmaceutical and medicinal aspects of Australian tea tree oil. Phytomedicine 5: 489-495.
25. SCCP. Scientific Committee on Consumer Products. 2008. Opinion on tea tree oil. Scientific Committee on Consumer Products 1155/08.
26. Singh G, Maurya S, DeLampasona MP, Catalan CA,. 2007. A comparison of chemical, antioxidant and antimicrobial studies of cinnamon leaf and bark volatile oils, oleoresins and their constituents. Food Chem Toxicol 45: 1650-1661.
27. Thomsen PS, Jensen TM, Hammer KA, Carson CF, Mølgaard P, Riley TV,. 2011. Survey of the antimicrobial activity of commercially available Australian tea tree (Melaleuca alternifolia) essential oil products in vitro. J Altern Complement Med 17: 835-841.
28. Van Vuuren SF, Suliman S, Viljoen AM,. 2009. The antimicrobial activity of four commercial essential oils in combination with conventional antimicrobials. Lett Appl Microbiol 48: 440-446.
29. Watson CJ, Pirotta M, Myers SP,. 2012. Use of complementary and alternative medicine in recurrent vulvovaginal candidiasis-results of a practitioner survey. Complement Ther Med 20: 218-21.
30. Yap PS, Lim SH, Hu CP, Yiap BC,. 2013. Combination of essential oils and antibiotics reduce antibiotic resistance in plasmid-conferred multidrug resistant bacteria. Phytomedicine 20: 710-3.